DETAILED ACTION
Notice of Pre-AIA or AIA Status
The present application, filed on or after March 16, 2013, is being examined under the first inventor to file provisions of the AIA .
Election/Restrictions
Applicant's election with traverse of Group II with metal complex species of formula (I-C) in the reply filed on June 23, 2026 is acknowledged. The traversal is on the ground(s) that any comprehensive search would invariably encompass both of the claimed metal complexes and uses therefor. This is not found persuasive because the inventions require a different field of search (e.g., searching different classes/subclasses or electronic resources, or employing different search strategies). Moreover, Applicants have not submitted evidence or identified such evidence now of record showing the inventions to be obvious variants or clearly admitted on the record that this is the case. In either instance, if the examiner finds one of the inventions unpatentable over the prior art, the evidence or admission may be used in a rejection under 35 U.S.C. 103 or pre-AIA 35 U.S.C. 103(a) of the other invention.
The requirement is still deemed proper and is therefore made FINAL.
Claims 1-11 are withdrawn from further consideration pursuant to 37 CFR 1.142(b), as being drawn to a nonelected group, there being no allowable generic or linking claim. Applicant timely traversed the restriction (election) requirement in the reply filed on June 23, 2026.
Claim Rejections - 35 USC § 112
Claims 12-14 and 16 are rejected under 35 U.S.C. 112(b) or 35 U.S.C. 112 (pre-AIA ), second paragraph, as being indefinite for failing to particularly point out and distinctly claim the subject matter which the inventor or a joint inventor (or for applications subject to pre-AIA 35 U.S.C. 112, the applicant), regards as the invention.
In claim 12, it is unclear whether the Cyc ligand is bonded to the L ligand in the metal complex of formula (I). In this regard, the metal complexes depicted in the specification disclosure (e.g., page 6) show the Cyc ligand bonded to the metal M, rather than to the L ligand. Clarification is requested.
In claim 12, the nature of the optional “substituents” defining the Cyc ligand in the metal complex of formula (I) are indeterminate in scope.
In claim 12, it is unclear what is meant by a “pseudohalogen” defining ligand Z in the metal complex of formula (I).
In claim 12, it is unclear how the narrower “preferably” limitation further limits the antecedently-recited broader Z ligand in the metal complex of formula (I). The claim is considered indefinite because there is a question or doubt as to whether the feature introduced by such narrower language is (a) merely exemplary of the remainder of the claim, and therefore not required, or (b) a required feature of the claims.
In claim 12, “sulfilimine-type” renders the claim indefinite because the claim includes elements not actually disclosed (those encompassed by "type"), thereby rendering the scope of the claim unascertainable. See MPEP § 2173.05(d).
In claim 13, it is unclear how the narrower monomer composition (lines 5-7), which further includes propylene, further limits the antecedently-recited broader monomer composition (lines 2-4), which does not require propylene. The claim is considered indefinite because there is a question or doubt as to whether the feature introduced by such narrower language is (a) merely exemplary of the remainder of the claim, and therefore not required, or (b) a required feature of the claims.
Allowable Subject Matter
Present claims 12-4 and 16 are deemed allowable over the prior art of record in that said art neither discloses nor renders obvious a process for preparing an ethylene polymer in the presence of the presently claimed metal complex. The closest prior art of record, US 2013/0131296 (Doremaele), discloses polymerizing olefins in the presence of a metal complex of formula CyLMD wherein L is an amidinate-containing ligand of formula
PNG
media_image1.png
53
79
media_image1.png
Greyscale
(having nitrogen double bonded to carbon) wherein Sub1 and Sub2 are preferably aromatic residues. Doremaele, however, fails to disclose, suggest or provide motivation for using a sulfilimine ligand having a nitrogen double bonded to sulfur as presently claimed in place of said amidinate-containing ligand.
Conclusion
Any inquiry concerning this communication or earlier communications from the examiner should be directed to Ana L Woodward whose telephone number is (571)272-1082. The examiner can normally be reached M-F 8am-5pm.
Examiner interviews are available via telephone, in-person, and video conferencing using a USPTO supplied web-based collaboration tool. To schedule an interview, applicant is encouraged to use the USPTO Automated Interview Request (AIR) at http://www.uspto.gov/interviewpractice.
If attempts to reach the examiner by telephone are unsuccessful, the examiner’s supervisor, Heidi Kelley can be reached at 571-270-1831. The fax phone number for the organization where this application or proceeding is assigned is 571-273-8300.
Information regarding the status of published or unpublished applications may be obtained from Patent Center. Unpublished application information in Patent Center is available to registered users. To file and manage patent submissions in Patent Center, visit: https://patentcenter.uspto.gov. Visit https://www.uspto.gov/patents/apply/patent-center for more information about Patent Center and https://www.uspto.gov/patents/docx for information about filing in DOCX format. For additional questions, contact the Electronic Business Center (EBC) at 866-217-9197 (toll-free). If you would like assistance from a USPTO Customer Service Representative, call 800-786-9199 (IN USA OR CANADA) or 571-272-1000.
/ANA L. WOODWARD/Primary Examiner, Art Unit 1765